These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

99 related items for PubMed ID: 10634001

  • 1. Prevalence of factor V Leiden in the Chinese population.
    Ho CH, Chau WK, Hsu HC, Gau JP, Chih CM.
    Zhonghua Yi Xue Za Zhi (Taipei); 1999 Dec; 62(12):875-8. PubMed ID: 10634001
    [Abstract] [Full Text] [Related]

  • 2. Prevalence of resistance against activated protein C resulting from factor V Leiden is significantly increased in myocardial infarction: investigation of 507 patients with myocardial infarction.
    Middendorf K, Göhring P, Huehns TY, Seidel D, Steinbeck G, Nikol S.
    Am Heart J; 2004 May; 147(5):897-904. PubMed ID: 15131548
    [Abstract] [Full Text] [Related]

  • 3. Activated protein C resistance and factor V Leiden in Mexico.
    Majluf-Cruz A, Moreno-Hernández M, Ruiz-de-Chávez-Ochoa A, Monroy-García R, Majluf-Cruz K, Guardado-Mendoza R, Molina-Avila I, Isordia-Salas I, Corona-de la Peña N, Vargas-Vorackova F, Vela-Ojeda J, García-Chávez J.
    Clin Appl Thromb Hemost; 2008 Oct; 14(4):428-37. PubMed ID: 18160617
    [Abstract] [Full Text] [Related]

  • 4. Factor V Leiden mutation and type 1 diabetes mellitus.
    Demirer AN, Alikasifoglu M, Tuncbilek E, Karakus S, Erbas T.
    Blood Coagul Fibrinolysis; 2008 Jan; 19(1):70-4. PubMed ID: 18180619
    [Abstract] [Full Text] [Related]

  • 5. The prevalence of factor V Leiden as a risk factor for venous thromboembolism in the population of North-Western Greece.
    Ioannou HV, Mitsis M, Eleftheriou A, Matsagas M, Nousias V, Rigopoulos C, Vartholomatos G, Kappas AM.
    Int Angiol; 2000 Dec; 19(4):314-8. PubMed ID: 11305729
    [Abstract] [Full Text] [Related]

  • 6. Prevalence of factor V Leiden mutation and other hereditary thrombophilic factors in Egyptian children with portal vein thrombosis: results of a single-center case-control study.
    El-Karaksy H, El-Koofy N, El-Hawary M, Mostafa A, Aziz M, El-Shabrawi M, Mohsen NA, Kotb M, El-Raziky M, El-Sonoon MA, A-Kader H.
    Ann Hematol; 2004 Nov; 83(11):712-5. PubMed ID: 15309526
    [Abstract] [Full Text] [Related]

  • 7. Combined effect of factor V Leiden and prothrombin 20210A on the risk of venous thromboembolism--pooled analysis of 8 case-control studies including 2310 cases and 3204 controls. Study Group for Pooled-Analysis in Venous Thromboembolism.
    Emmerich J, Rosendaal FR, Cattaneo M, Margaglione M, De Stefano V, Cumming T, Arruda V, Hillarp A, Reny JL.
    Thromb Haemost; 2001 Sep; 86(3):809-16. PubMed ID: 11583312
    [Abstract] [Full Text] [Related]

  • 8. The risk of mortality and the factor V Leiden mutation in a population-based cohort.
    Heijmans BT, Westendorp RG, Knook DL, Kluft C, Slagboom PE.
    Thromb Haemost; 1998 Oct; 80(4):607-9. PubMed ID: 9798979
    [Abstract] [Full Text] [Related]

  • 9. The prevalence of activated protein C (APC) resistance and factor V Leiden is significantly higher in patients with retinal vein occlusion without general risk factors. Case-control study and meta-analysis.
    Rehak M, Rehak J, Müller M, Faude S, Faude F, Siegemund A, Krcova V, Slavik L, Hasenclever D, Scholz M, Wiedemann P.
    Thromb Haemost; 2008 May; 99(5):925-9. PubMed ID: 18449423
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Factor V Leiden mutation in one family of Chinese origin.
    Wu J, Gu J, Xu J, Wang J, Sun Z, Smirnov MD, Morrissey JH, Esmon N.
    Chin Med J (Engl); 2001 Apr; 114(4):379-81. PubMed ID: 11780458
    [Abstract] [Full Text] [Related]

  • 12. [Factor V Leiden and the Slovak population].
    Hudecek J, Dobrotová M, Hybenová J, Ivanková J, Melus V, Pullmann R, Kubisz P.
    Vnitr Lek; 2003 Nov; 49(11):845-50. PubMed ID: 14689680
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Inherited thrombophilia is associated with deep vein thrombosis in a Colombian population.
    Torres JD, Cardona H, Alvarez L, Cardona-Maya W, Castañeda SA, Quintero-Rivera F, Cadavid A, Bedoya G, Tobón L.
    Am J Hematol; 2006 Dec; 81(12):933-7. PubMed ID: 16917913
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Screening with the activated protein C resistance assay yields significant savings in a patient population with low prevalence of factor V leiden.
    Taylor LJ, Oster RA, Fritsma GA, Tichenor PH, Reed CE, Eiland BM, Hudson CL, Marques MB.
    Am J Clin Pathol; 2008 Mar; 129(3):494-9. PubMed ID: 18285275
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Activated protein C resistance due to factor V Leiden, elevated coagulation factor VIII and postoperative deep vein thrombosis in late breast reconstruction with a free TRAM flap: a report of two cases.
    Olsson E, Höijer P.
    Br J Plast Surg; 2005 Jul; 58(5):720-3. PubMed ID: 15992531
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.